As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
As Of June 30, 2024, BioLineRx Had Cash, Cash Equivalents, And Short-term Bank Deposits Of $40.1M Expected To Be Sufficient To Fund Operations, As Currently Planned, Into 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.